JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

Hong Kong · Delayed Price · Currency is HKD

1.920

+0.040 (2.13%)

Mar 6, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals	158.22M	173.86M	145.70M	30.80M		5.48M
Pharmaceuticals Growth	-8.99%	19.32%	373.10%	-		2450.23%
Total	158.22M	173.86M	145.70M	30.80M		5.48M
Total Growth	-8.99%	19.32%	373.10%	-		2450.23%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
People's Republic of China (PRC)	158.22M	173.86M	145.70M	30.80M		5.48M
People's Republic of China (PRC) Growth	-8.99%	19.32%	373.10%	-		2450.23%
Total	158.22M	173.86M	145.70M	30.80M		5.48M
Total Growth	-8.99%	19.32%	373.10%	-		2450.23%

Source: S&P Global Market Intelligence.